Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2019-10-15 2019-08-14
Drug Identification Number 02398591 02398591
Brand name APO-CLOPIDOGREL APO-CLOPIDOGREL
Common or Proper name CLOPIDOGREL CLOPIDOGREL
Company Name APOTEX INC APOTEX INC
Ingredients CLOPIDOGREL CLOPIDOGREL
Strength(s) 300MG 300MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 BLS 30 BLS
ATC code B01AC B01AC
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-08-13 2019-08-13
Estimated end date 2019-10-24 2019-10-24
Actual end date 2019-10-11
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments